Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Spondylitis, Ankylosing 1Psoriasis 1Melanoma 1Lupus Erythematosus, Systemic 1Inflammatory Bowel Diseases 1Hematologic Neoplasms 1Crohn Disease 1Colitis, Ulcerative 1Clinical Stage 0 Gastric Cancer AJCC v8 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthritis, Reactive 1Arthritis, Psoriatic 1

Interventions

Etanercept 6Adalimumab 6Infliximab 5tocilizumab 3golimumab 3Tumor Necrosis Factor Inhibitors 3tofacitinib 2Rituximab 2Certolizumab Pegol 2Surveys and Questionnaires 1Standard of Care 1Practice Guidelines as Topic 1Phlebotomy 1Observation 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1Dietary Fiber 1CT-P13 1Antirheumatic Agents 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Arthritis, Rheumatoid × Practice Guidelines as Topic × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡